István Molnár
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 5
-
- Thyroid Cancer Diagnosis and Treatment 10
- Co-authors
- Lars Bastholt (8 shared papers)Barbara Jarząb (8 shared papers)Rossella Elisei (8 shared papers)Young Kee Shong (9 shared papers)Christelle de la Fouchardière (8 shared papers)Johannes W. A. Smit (9 shared papers)Salvatore Siena (7 shared papers)Furio Pacini (5 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Experimental and Clinical Endocrinology & Diabetes (4 papers)Blood (3 papers)British Journal of Cancer (2 papers)Leukemia Research (2 papers)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
István Molnár
43 papers receiving 2.0k citations
István Molnár's Hit Papers
Peers
Comparison fields: 5 of 99
- Endocrinology, Diabetes and Metabolism 1.0k
- Oncology 566
- Hematology 188
- Internal Medicine 53
- Genetics 126
Countries citing papers authored by István Molnár
This map shows the geographic impact of István Molnár's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Molnár with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Molnár more than expected).
Fields of papers citing papers by István Molnár
This network shows the impact of papers produced by István Molnár. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Molnár. The network helps show where István Molnár may publish in the future.
Co-authors
The 25 scholars most cited alongside István Molnár, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2014 | 1153 |
| 2 | 2016 | 124 | |
| 3 | 2018 | 95 | |
| 4 | 2004 | 74 | |
| 5 | 2013 | 61 | |
| 6 | 2007 | 59 | |
| 7 | 2017 | 45 | |
| 8 | 2013 | 41 | |
| 9 | 2013 | 41 | |
| 10 | 1992 | 39 | |
| 11 | 2008 | 33 | |
| 12 | 2009 | 31 | |
| 13 | 1988 | 28 | |
| 14 | 2014 | 27 | |
| 15 | 2011 | 25 | |
| 16 | 1988 | 25 | |
| 17 | 2015 | 24 | |
| 18 | 2007 | 22 | |
| 19 | 2019 | 17 | |
| 20 | 2008 | 14 |
About István Molnár
István Molnár is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Hematology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Iron Metabolism and Disorders (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Trace Elements in Health (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.0k citations), Oncology (566 citations), Hematology (188 citations), Internal Medicine (53 citations) and Genetics (126 citations). István Molnár has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Lars Bastholt, Barbara Jarząb, Rossella Elisei, Young Kee Shong, Christelle de la Fouchardière, Johannes W. A. Smit, Salvatore Siena, Furio Pacini, John Chung and Marcia S. Brose. Their work appears in journals such as Journal of Clinical Oncology, Experimental and Clinical Endocrinology & Diabetes, Blood, British Journal of Cancer and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.